Cargando…
Implications of Tau Dysregulation in Huntington’s Disease and Potential for New Therapeutics
Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder. The disease, characterized by motor, cognitive, and psychiatric impairments, is caused by the expansion of a CAG repeat in the huntingtin gene. Despite the discovery of the mutation in 1993, no disease-modifying treatment...
Autores principales: | Mees, Isaline, Nisbet, Rebecca M., Hannan, Anthony J., Renoir, Thibault |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200226/ https://www.ncbi.nlm.nih.gov/pubmed/37092231 http://dx.doi.org/10.3233/JHD-230569 |
Ejemplares similares
-
Phosphoproteomic dysregulation in Huntington’s disease mice is rescued by environmental enrichment
por: Mees, Isaline, et al.
Publicado: (2022) -
Hippocampal Neurogenesis, Cognitive Deficits and Affective Disorder in Huntington's Disease
por: Ransome, Mark I., et al.
Publicado: (2012) -
Effect of enhanced voluntary physical exercise on brain levels of monoamines in Huntington disease mice
por: Renoir, Thibault, et al.
Publicado: (2011) -
Sexually Dimorphic Serotonergic Dysfunction in a Mouse Model of Huntington's Disease and Depression
por: Renoir, Thibault, et al.
Publicado: (2011) -
Gene-environment-gut interactions in Huntington's disease mice are associated with environmental modulation of the gut microbiome
por: Gubert, Carolina, et al.
Publicado: (2021)